Initiation and Titration of Insulin Analogs in the Patient with Type 2 Diabetes
Please read the following information and select the appropriate link at the bottom of the page to continue.
This activity is intended for pharmacists, nurses, and dietitians who care for patients with type 2 diabetes.
The goal of this program is to provide information to healthcare professionals about when and how to initiate therapy with insulin analogs and how to adjust insulin therapy when needed.
Upon completion of this activity, the participant should be able to:
- Discuss the epidemiology, pathophysiology, and treatment goals of type 2 diabetes in the United States
- Review the advantages of insulin analogs based on pharmacokinetics and pharmacodynamics
- Explain why, when, and how to initiate insulin in a patient with type 2 diabetes, including overcoming insulin resistance
- Discuss factors that must be considered when initiating and adjusting insulin regimens
Pharmacists: The American Association of Diabetes Educators is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.50 contact hours (0.150 CEU) of continuing education credit. ACPE Universal Program Number: 069-999-08-007-H01-P.
Registered Nurses: This continuing nursing education activity was approved by the American Association of Diabetes Educators, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This program 0607-118 is approved for 1.50 contact hours.
Dietitians: American Association of Diabetes Educators (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR) from June 1, 2006 to May 31, 2009. Registered dietitians (RD) and dietetic technicians, registered (DTR) will receive 1.50 Continuing Professional Education Units (CPEU) for completion of this program. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.
Release Date: February 25, 2008
Expiration Date: February 25, 2010
To Receive a Statement of Credit, You Must:
- Successfully complete the post-test within 2 attempts (80% or better)
- Complete the program evaluation
Your statement of credit will be issued immediately upon successful completion of the test and submission of the evaluation form. The statement of credit specific to your discipline will appear on your screen and you will be given the option to print it for your files. No additional statement of credit will be issued.
Deborah Hinnen, RN, ARNP, BC-ADM, CDE, FAAN
Mid America Diabetes Associates
The following program is a taped presentation by Deborah Hinnen.
Deborah Hinnen, RN, ARNP, BC-ADM, CDE, FAAN has been a diabetes educator for over thirty years. As a clinical nurse specialist and education coordinator, she currently works at Mid America Diabetes Associates as coordinator of a multidisciplinary team. The centerpiece of their program is a three day comprehensive self-management course that serves nearly 1000 people with diabetes per year. Ms. Hinnen is involved extensively with the American Association of Diabetes Educators, having served as their national President in 1993-94. She was awarded their prestigious Distinguished Service Award in the summer of 2001. She has also served on the national board of directors for the American Diabetes Association, and is currently one the editors for Diabetes Spectrum. She continues to volunteer with many other organizations. Her faculty positions are with the Pharmacy Department at University of Kansas, and Graduate Nursing Department at Wichita State University and the Physicians Assistant Program at Wichita State. Ms. Hinnen was inducted as a Fellow into the American Academy of Nursing in 2003. Her career has focused on diabetes patient and professional education with many publications in both areas. In addition to diabetes efforts, she is currently serving as a Trustee for Butler Community College, a college with seven sites and more than 14,000 students.
There is no fee to receive credits for this continuing education activity.
This program is supported by an educational grant from Novo Nordisk Inc.
- Byetta and Symlin are registered trademarks of Amylin Pharmaceuticals, Inc.
- Lantus and Apidra are registered trademarks of Aventis Pharmaceuticals.
- Humalog and Humulin are registered trademarks of Eli Lilly and Company.
- Mix75/25 and Mix50/50 are trademarks of Eli Lilly and Company.
- Levemir, Novolin, and NovoLog are registered trademarks of Novo Nordisk A/S.
It is the policy of the American Association of Diabetes Educators and Scherer Clinical Communications to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.
The faculty must disclose to the participants any significant relationships with the commercial companies whose products or devices may be mentioned in the activity or with the supporter of this continuing education activity. The information is for participant information; it is not assumed that these relationships will have a negative impact on the content of the activity.
Deborah Hinnen has disclosed that she has received an honorarium for narrating this activity.
- Approval of credit for this continuing education program does not imply endorsement by AADE of any product or manufacturer identified.
- Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
- This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA).
- The American Association of Diabetes Educators, Scherer Clinical Communications, the commercial supporter, and the activity’s faculty do not endorse the use of any product in a manner that is not approved by the FDA.
The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Click the appropriate profession to continue to the activity:
Copyright© 2008 Scherer Clinical Communications. All rights reserved.